| Dr Leanna Marie Mosher, MD | |
|
19550 E 39th St S, Suite 310, Independence, MO 64057-2303 | |
| (816) 350-1828 | |
| (816) 350-1844 |
| Full Name | Dr Leanna Marie Mosher |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 19550 E 39th St S, Independence, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407050081 | NPI | - | NPPES |
| 2006036876 | Other | MO | 17 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2006036876 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males.
A research team led by Professor Hongzhe SUN, Chair Professor from the Department of Chemistry, Faculty of Science, in collaboration with Dr Pak-Leung HO, Director of the HKU Carol Yu Centre for Infection from the Department of Microbiology, Li Ka Shing Faculty of Medicine.
› Verified 6 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males.
A research team led by Professor Hongzhe SUN, Chair Professor from the Department of Chemistry, Faculty of Science, in collaboration with Dr Pak-Leung HO, Director of the HKU Carol Yu Centre for Infection from the Department of Microbiology, Li Ka Shing Faculty of Medicine.
› Verified 6 days ago
| Entity Name | Lintecum & Nickell Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447211537 PECOS PAC ID: 1850280488 Enrollment ID: O20040312000186 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males.
A research team led by Professor Hongzhe SUN, Chair Professor from the Department of Chemistry, Faculty of Science, in collaboration with Dr Pak-Leung HO, Director of the HKU Carol Yu Centre for Infection from the Department of Microbiology, Li Ka Shing Faculty of Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leanna Marie Mosher, MD 19550 E 39th St S, Suite 310, Independence, MO 64057-2303 Ph: (816) 350-1828 | Dr Leanna Marie Mosher, MD 19550 E 39th St S, Suite 310, Independence, MO 64057-2303 Ph: (816) 350-1828 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.
Researchers at Weill Cornell Medical College have shown that it is possible to immunize mammals to control fertility. They say their technique could possibly be used on other mammals - including humans - because fertility hormones and their receptors are species-non-specific and are similar in both females and males.
A research team led by Professor Hongzhe SUN, Chair Professor from the Department of Chemistry, Faculty of Science, in collaboration with Dr Pak-Leung HO, Director of the HKU Carol Yu Centre for Infection from the Department of Microbiology, Li Ka Shing Faculty of Medicine.
› Verified 6 days ago
Thomas Mathews, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 17221 E 23rd St S, Suite #300, Independence, MO 64057 Phone: 816-373-8822 Fax: 816-373-8885 | |
Kiersten M Moreno, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19500 E 39th Street, Suite 300, Independence, MO 64057 Phone: 816-478-0220 Fax: 816-795-3456 | |
Dr. Thomas R Dowd, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4811 S Arrowhead Dr, Independence, MO 64055 Phone: 816-356-5000 Fax: 913-495-3742 | |
Dr. Alisa R Ash, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19550 E 39th St S, Suite 300, Independence, MO 64057 Phone: 816-478-0220 Fax: 816-795-3456 | |
Clayton Southern, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 19550 E 39th St S Ste 300, Independence, MO 64057 Phone: 816-478-0220 | |
Dr. Robert Thomas Caffrey, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19550 E 39th St S, Ste 300, Independence, MO 64057 Phone: 816-478-0220 Fax: 816-795-3456 |